Semaglutide is a Glucagon-like Peptide-1 (GLP-1) Receptor Agonist that mimics a natural hormone (GLP-1) released after eating. It increases insulin release, improves blood sugar control, slows stomach emptying, and reduces appetite.
In contrast, Ozempic is an FDA-approved brand containing semaglutide. It is manufactured by Novo Nordisk and is mainly prescribed to tr...